Viewing nowCombinationLozadin Plus Tablet
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.

MFDS item code 202000847 · Approved 2020.02.12 · Insurance code 628901580
Treatment of hypertension not controlled with monotherapy
This medication is used for patients with hypertension who have difficulty controlling blood pressure with monotherapy.
○ Adults The usual dose of this medicine is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. In general, the maximum blood pressure-lowering effect is achieved after approximately 3 weeks of treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, initiate treatment with this medicine only when the expected effect has not been achieved with monotherapy. 1. Replacement therapy: Treatment with separately titrated losartan potassium and hydrochlorothiazide may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who develop hypokalemia despite blood pressure control at this dose: Treatment may be started with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which can reduce the hydrochlorothiazide dose without reducing the overall blood pressure-lowering effect. Thereafter, the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg should be monitored continuously. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment Use the usual dose when creatinine clearance is 30 mL/min or greater. Use in patients with more severe renal impairment is not recommended, as loop diuretics are preferable to thiazide-type drugs in these patients. ○ Patients with hepatic impairment Use in these patients is not recommended because this medicine cannot provide the 25 mg initial dose of losartan potassium required for patients with hepatic impairment who need dose adjustment.
Children (under 18 years): The losartan-hydrochlorothiazide combination should not be administered to children or adolescents because there is no experience with its use in this population.
This medication can cause severe harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. This drug should not be administered to patients with certain diseases or conditions. For example, patients with severely impaired renal function or a history of specific allergies should not take this medication. Patients with very low blood pressure or those with renal or liver dysfunction should use this drug cautiously and consult healthcare professionals for proper management. This medication can cause electrolyte imbalances, so regular blood tests should be conducted to monitor electrolyte status, and any unusual symptoms should be reported immediately. Hydrochlorothiazide can make the skin sensitive to sunlight and increase the risk of skin cancer, so sun protection and skin care should be prioritized while taking it. Dizziness or drowsiness may occur during the use of this drug, so caution is needed when driving or operating machinery. There may be interactions with other medications, so all medications being taken should be disclosed to healthcare professionals, especially potassium supplements or certain diuretics to avoid concomitant use. Women who are breastfeeding should discontinue either breastfeeding or this medication, as it may be transmitted through breast milk and affect the baby. Safety and efficacy in children and adolescents have not been established, so this medication should not be used in pediatric populations. Elderly patients may experience side effects more frequently, so careful monitoring is required during use. In case of overdose, symptoms may include hypotension and arrhythmias, so immediate medical attention is required for appropriate treatment. This medication should be kept out of reach of children and stored in its original container to prevent misuse or degradation of quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a tightly sealed container that blocks light. The storage temperature should be maintained at room temperature between 1°C and 30°C. Storing it this way helps maintain the effectiveness and safety of the medication.
Yellow oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.